Targeting Polyamines using DFMO in Persons with Type 1 Diabetes: A Randomized Double-Masked Placebo-Controlled Phase I/II Study to Evaluate the Safety Tolerability and Initial Pharmacodynamics of Multiple Ascending Doses

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: type 1 diabetes
  • Age: Between 12 - 40 Years
  • Gender: Male or Female

Inclusion Criteria
Clinical diagnosis of type 1 diabetes within 2-8 months
Normal hearing
Exclusion Criteria
Presence of severe, active disease that interferes with dietary intake or requires the use of chronic medication, with exception of well-controlled hypothyroidism and mild asthma not requiring oral steroids
Diabetes other than T1D
Chronic illness known to affect glucose metabolism
Inability to swallow pills
Psychiatric impairment or current use of anti-psychotic medication
Hematologic abnormalities
Impaired renal function
Pregnant

Recruitment Status

Open

Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

If you need assistance finding a study or if you have any questions, please email: ctsirro@iu.edu or call us at (317) 278-2176